COMET: a multicomponent home-based disease-management programmeversusroutine care in severe COPD

Abstract

The COPD Patient Management European Trial (COMET) investigated the efficacy and safety of a home-based COPD disease management intervention for severe COPD patients.The study was an international open-design clinical trial in COPD patients (forced expiratory volume in 1 s <50% of predicted value) randomised 1:1 to the disease management intervention or to the usual management practices at the study centre. The disease management intervention included a self-management programme, home telemonitoring, care coordination and medical management. The primary end-point was the number of unplanned all-cause hospitalisation days in the intention-to-treat (ITT) population. Secondary end-points included acute care hospitalisation days, BODE (body mass index, airflow obstruction, dyspnoea and exercise) index and exacerbations. Safety end-points included adverse events and deaths.For the 157 (disease management) and 162 (usual management) patients eligible for ITT analyses, all-cause hospitalisation days per year (mean±sd) were 17.4±35.4 and 22.6±41.8, respectively (mean difference -5.3, 95% CI -13.7 to -3.1; p=0.16). The disease management group had fewer per-protocol acute care hospitalisation days per year (p=0.047), a lower BODE index (p=0.01) and a lower mortality rate (1.9% 14.2%; p<0.001), with no difference in exacerbation frequency. Patient profiles and hospitalisation practices varied substantially across countries.The COMET disease management intervention did not significantly reduce unplanned all-cause hospitalisation days, but reduced acute care hospitalisation days and mortality in severe COPD patients.

Prediction of severe acute exacerbation using changes in breathing pattern of COPD patients on home noninvasive ventilation

“…New ventilators now have built-in transmission unit that allows tele-monitoring, and this has been shown to be feasible in NIV patients 19. Therefore, our results could be used for remote early identification of severe AECOPD that may avoid hospitalization.…”

Development and validation of a simple tool for the assessment of home noninvasive ventilation: the S3-NIV questionnaire

“…In this particular setting, it could be very beneficial to merge the data downloaded from the built-in software with a brief self-administered questionnaire in an integrated e-health platform tailored to patients' needs and NIV services. This paradigm shift in care planning has already been tested with success in cancer patients [25], as well as in severe COPD [26] and sleep apnea [27].…”

Respiratory Muscle Training Improves Speech and Pulmonary Function in COPD Patients in a Home Health Setting - a Pilot Study

“…Home-based COPD management interventions such as patient activation, active monitoring of adherence, care coordination and medical management reduce sedentary behavior and increase physical activity levels. Furthermore, home-based COPD management reduces healthcare utilization, acute care hospitalization days, and mortality [8,9] .…”